| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Wales Heart Research Institute, Department of Diagnostic Radiology, Cardiff University, Cardiff, United Kingdom; and
Division of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, Australia
Correspondence: Address reprint requests to Professor T. M. Griffith, Wales Heart Research Institute, Dept. of Diagnostic Radiology, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK. Tel.: 44-2920–743070; Fax: 44-2920–744726; E-mail: Griffith{at}Cardiff.ac.uk.
The effects of pharmacological interventions that modulate Ca2+ homeodynamics and membrane potential in rat isolated cerebral vessels during vasomotion (i.e., rhythmic fluctuations in arterial diameter) were simulated by a third-order system of nonlinear differential equations. Independent control variables employed in the model were [Ca2+] in the cytosol, [Ca2+] in intracellular stores, and smooth muscle membrane potential. Interactions between ryanodine- and inositol 1,4,5-trisphosphate-sensitive intracellular Ca2+ stores and transmembrane ion fluxes via K+ channels, Cl– channels, and voltage-operated Ca2+ channels were studied by comparing simulations of oscillatory behavior with experimental measurements of membrane potential, intracellular free [Ca2+] and vessel diameter during a range of pharmacological interventions. The main conclusion of the study is that a general model of vasomotion that predicts experimental data can be constructed by a low-order system that incorporates nonlinear interactions between dynamical control variables.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |